Alt tag

icolung ct

  • CT
  • Covid-19

icolung ct supports automatic labeling, visualization and volumetric quantification of segmentable lung structures from non-contrast enhanced chest CT. It also measures the percentage of abnormality (Ground Glass Opacity, Consolidation and their total sum) in each lobe and in total lungs.

Icolung

Images shown for illustrative purposes only.

Circle

~29% and ~21% improved nodules detection

Riverain's AI suppression technology removes structures that can camouflage cancer and lung disease. 1,2

Circle

~26% and ~20% faster nodule search time

ClearRead CT technology helps radiologists see through the complexity to better detect abnormalities.1,2

Circle

Higher inter-reader agreement rates2

Clinical Workflow

Icolung workflow

For CalanticTM software version 1.0.0, no prior study will be examined.

white bg

 

    Scanning Parameters

    Appropriate Series

    Non-contrast chest CT

    Kilovoltage peak (kVp): 80-140

    Recommended slice thickness: 1mm

    Maximum slice thickness: 5mm

    Maximum Pixel spacing: 1mm

    AI Output

    The percentage affected lung tissue with different types of abnormalities: Ground GlassOpacity (GGO) and Consolidation (CO), (including their sum) in five lobes of the lungs (left upper, left lower, right upper, right middle, right lower) and total lungs and a severity score based on the percentage (each lobe receives a score between 0 and 5).

    What Customers Are Saying

    We have been testing the first versions of icolung, and believe that quantitative CT data is important. Thanks to the cloud, improvements of the Al algorithm are instantly available to us, which is essential in this rapidly evolving pandemic.

    Prof. Johan De Mey, Head of Radiology at the University Hospital of Brussels.

    May not reflect a typical user experience; actual results may vary.

    The customer providing this testimonial is a paid consultant of this app vendor.

      Other Relevant Information

      Vendor
      Icometrix.

      EU risk class and CE marking
      Icolung ct has CE marking (CE1639) and risk class Im.

      Reimbursement status
      Not reimbursed.

      Contraindications
      No contraindications given.

      Patient Target Group
      Patients with potential lung disease.

      Limitations

      Artifacts and anatomical deviations: Please make sure the images are free of artifacts, as these might have a negative impact on the results of fully automatic measurements. Even without artifacts or extensive deviations in anatomy, automatic measurements are subject to errors, intrinsically associated with the measurement device. The technical validation of the measurements attempts to provide an idea of the extent of these errors.

        References
        1.
        Instructions for Use icolung ct, software version 0.7.2
        App gallery wave image
        Discover ClearRead CT

        Discover Icolung ct

        Now available as part of Calantic’s Thoracic Service Line. Contact us today to learn more.

        Get a Demo

        Other Offerings in the Thoracic Service Line

        Nanoxai
        Thoracic

        HealthPNX+ Device

        • Xray
        • Chest
        • Pneumothorax
        • Worklist Prioritisation

        Learn More

        Nanoxai
        Thoracic

        HealthCXR Device

        • Xray
        • Chest
        • Pleural Effusion
        • Worklist Prioritisation

        Learn More

        Riverain technologies logo
        Thoracic

        ClearRead CT

        • Analysis
        • CT
        • Lung Nodules

        Learn More

        VIDA
        Thoracic

        VIDA Insights

        • CT
        • Pulmonary
        • Thoracic
        • COPD
        • ILA

        Learn More

        Bayer Logo

        © 2023 Bayer

        The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

        BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners.

        This is intended to provide information for healthcare professionals and other relevant decision makers in the European Union, United Kingdom and Switzerland. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

         

        The product Calantic Viewer has CE marking (CE2797). Complies with medical device legislation. Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information. The operating instructions of the product Calantic Viewer can be found on https://www.radiology.bayer.com/manuals

         

        You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

        Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

         

        PP-CALA-GB-0210 December 2023